Alzheimer's disease marker phospho-tau181 is not elevated in the first year after moderate-to-severe TBI.
Neil Samuel Nyholm GrahamKarl ZimmermanAmanda J HeslegraveAshvini KeshavanFederico MoroSamia Abed-MaillardAdriano BerniniVincent DunetElena GarberoGiovanni NattinoArturo ChieregatoEnrico FainardiCamelia BaciuPrimoz GradisekSandra MagnoniMauro OddoGuido BertoliniJonathan M SchottHenrik ZetterbergDavid James SharpPublished in: Journal of neurology, neurosurgery, and psychiatry (2023)
Plasma p-tau181 is not significantly elevated during the first year after moderate-to-severe TBI and levels do not relate to neuroimaging measures of neurodegeneration.